{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5078, "recent_count": 45, "transaction_limit": 160, "filters": {"q": "", "ticker": "TAK", "sector": "", "industry": "", "side": "", "start": "2026-06-17", "end": "2026-08-01"}, "summary": {"total": 45, "acquisition_count": 38, "disposal_count": 7, "acquisition_value": 0.0, "acquisition_value_label": "$0", "disposal_value": 125262601.3, "disposal_value_label": "$125.3M", "net_value": -125262601.3, "net_value_label": "$-125.3M", "flow_tone": "negative", "largest_value_label": "$82.0M", "top_sector": "Healthcare", "window_label": "17 Jun 2026 to 01 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 45, "value": "125262601.3000", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$125.3M"}], "days": [{"transaction_date": "2026-07-01", "acquisitions": 38, "disposals": 0, "total": 38, "bar_width": 100.0}, {"transaction_date": "2026-07-10", "acquisitions": 0, "disposals": 7, "total": 7, "bar_width": 18.4}], "side_mix": {"acquisitions": 38, "disposals": 7, "acquisition_share": 84.4, "disposal_share": 15.6}}, "company_flows": [{"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-specialty-generic/", "latest_transaction": "2026-07-10", "acquisitions": 38, "disposals": 7, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 125262601.3, "disposed_value_label": "$125.3M", "net_value": -125262601.3, "net_value_label": "$-125.3M", "acquisition_share": 84.4, "disposal_share": 15.6, "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}], "company_overview": [{"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "exchange": "NYSE", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-specialty-generic/", "latest_transaction": "2026-07-10", "filings": 45, "acquisitions": 38, "disposals": 7, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 125262601.3, "disposed_value_label": "$125.3M", "net_value": -125262601.3, "net_value_label": "$-125.3M", "acquisition_share": 84.4, "disposal_share": 15.6, "tone": "Net acquisition", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}], "transactions": [{"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-10", "executive": "FURUTA, MILANO", "executive_title": "Director, Chief Financial Officer", "security_type": "Tax Obligation Award", "side_code": "D", "side": "Disposal", "shares": 16619.0, "share_price": 4931.5, "transaction_value": 81956598.5, "fetched_at": "2026-07-30T11:06:27.398253+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-10", "executive": "IIJIMA, MASAMI", "executive_title": "Director", "security_type": "Tax Obligation Award", "side_code": "D", "side": "Disposal", "shares": 2152.0, "share_price": 4931.2, "transaction_value": 10611942.4, "fetched_at": "2026-07-30T11:06:27.410636+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-10", "executive": "TSUSAKA, MIKI", "executive_title": "Director", "security_type": "Tax Obligation Award", "side_code": "D", "side": "Disposal", "shares": 2152.0, "share_price": 4931.2, "transaction_value": 10611942.4, "fetched_at": "2026-07-30T11:06:27.400662+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-10", "executive": "GILLIS, STEVEN", "executive_title": "Director", "security_type": "Tax Obligation Award", "side_code": "D", "side": "Disposal", "shares": 1152.0, "share_price": 4931.2, "transaction_value": 5680742.4, "fetched_at": "2026-07-30T11:06:27.403465+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-10", "executive": "MARAGANORE, JOHN", "executive_title": "Director", "security_type": "Tax Obligation Award", "side_code": "D", "side": "Disposal", "shares": 1152.0, "share_price": 4931.2, "transaction_value": 5680742.4, "fetched_at": "2026-07-30T11:06:27.405985+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-10", "executive": "REED, KIMBERLY A.", "executive_title": "Director", "security_type": "Tax Obligation Award", "side_code": "D", "side": "Disposal", "shares": 1152.0, "share_price": 4931.2, "transaction_value": 5680742.4, "fetched_at": "2026-07-30T11:06:27.394074+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-10", "executive": "MIYABASHIRA, ASUKA", "executive_title": "President, Japan Pharma B.U.", "security_type": "Tax Obligation Award", "side_code": "D", "side": "Disposal", "shares": 1022.0, "share_price": 4931.4, "transaction_value": 5039890.8, "fetched_at": "2026-07-30T11:06:27.408164+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "BITETTI, TERESA MARIE", "executive_title": "President, OBU", "security_type": "American Depositary Shares", "side_code": "A", "side": "Acquisition", "shares": 43886.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.710809+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "BROUSSARD, BRUCE D", "executive_title": "Director", "security_type": "Tax Obligation Award", "side_code": "A", "side": "Acquisition", "shares": 1319.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.733986+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "BROUSSARD, BRUCE D", "executive_title": "Director", "security_type": "American Depositary Shares", "side_code": "A", "side": "Acquisition", "shares": 3800.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.671685+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "DUPREY, LAUREN RUSCKOWSKI", "executive_title": "Chief Transformation Officer", "security_type": "American Depositary Shares", "side_code": "A", "side": "Acquisition", "shares": 45140.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.708829+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "FARAJALLAH, AWNY SAMAAN BOTROS", "executive_title": "Chief Medical Officer", "security_type": "American Depositary Shares", "side_code": "A", "side": "Acquisition", "shares": 17554.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.697001+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "FURNEY, NATALIE ANNE MARIE", "executive_title": "Global General Counsel", "security_type": "American Depositary Shares", "side_code": "A", "side": "Acquisition", "shares": 43886.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.698998+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "FURUTA, MILANO", "executive_title": "Director, Chief Financial Officer", "security_type": "Tax Obligation Award", "side_code": "A", "side": "Acquisition", "shares": 4288.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.687476+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "FURUTA, MILANO", "executive_title": "Director, Chief Financial Officer", "security_type": "Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 12300.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.685435+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "GILLIS, STEVEN", "executive_title": "Director", "security_type": "Tax Obligation Award", "side_code": "A", "side": "Acquisition", "shares": 1319.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.727986+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "GILLIS, STEVEN", "executive_title": "Director", "security_type": "Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 3800.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.724034+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "GREENWAY, NICOLA DEIDRE PETAL", "executive_title": "Chief Human Resources Officer", "security_type": "American Depositary Shares", "side_code": "A", "side": "Acquisition", "shares": 22570.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.720135+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "IBRAHIM, RAMY RIAD AHMED", "executive_title": "President, PDT BU", "security_type": "American Depositary Shares", "side_code": "A", "side": "Acquisition", "shares": 25078.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.718263+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "IIJIMA, MASAMI", "executive_title": "Director", "security_type": "Tax Obligation Award", "side_code": "A", "side": "Acquisition", "shares": 1937.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.669815+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "IIJIMA, MASAMI", "executive_title": "Director", "security_type": "Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 1800.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.667452+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "KIM, JULIE SO-YOUNG", "executive_title": "Director, President and CEO", "security_type": "Tax Obligation Award", "side_code": "A", "side": "Acquisition", "shares": 7743.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.725901+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "KIM, JULIE SO-YOUNG", "executive_title": "Director, President and CEO", "security_type": "American Depositary Shares", "side_code": "A", "side": "Acquisition", "shares": 50434.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.712748+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "KIM, JULIE SO-YOUNG", "executive_title": "Director, President and CEO", "security_type": "Tax Obligation Award", "side_code": "A", "side": "Acquisition", "shares": 7741.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.716886+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "KIM, JULIE SO-YOUNG", "executive_title": "Director, President and CEO", "security_type": "Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 22800.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.714895+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "KIMURA, KOICHIRO", "executive_title": "Director", "security_type": "Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 1800.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.673880+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "KIMURA, KOICHIRO", "executive_title": "Director", "security_type": "Tax Obligation Award", "side_code": "A", "side": "Acquisition", "shares": 1937.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.675942+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "MARAGANORE, JOHN", "executive_title": "Director", "security_type": "Tax Obligation Award", "side_code": "A", "side": "Acquisition", "shares": 1319.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.731845+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "MARAGANORE, JOHN", "executive_title": "Director", "security_type": "Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 3800.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.729938+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "MIYABASHIRA, ASUKA", "executive_title": "President, Japan Pharma B.U.", "security_type": "Tax Obligation Award", "side_code": "A", "side": "Acquisition", "shares": 666.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.695444+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "MIYABASHIRA, ASUKA", "executive_title": "President, Japan Pharma B.U.", "security_type": "Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 1500.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.681137+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "MIYABASHIRA, ASUKA", "executive_title": "President, Japan Pharma B.U.", "security_type": "Tax Obligation Award", "side_code": "A", "side": "Acquisition", "shares": 664.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.683240+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "PACHECO, RHONDA JANICE", "executive_title": "President, U.S. Business Unit", "security_type": "American Depositary Shares", "side_code": "A", "side": "Acquisition", "shares": 50156.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.701192+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "PIGNAGNOLI, AGOSTI MARCELLO", "executive_title": "Head, Strat. & Port. Dev.", "security_type": "American Depositary Shares", "side_code": "A", "side": "Acquisition", "shares": 27586.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.703176+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "PLATFORD, GILES RICHARD", "executive_title": "President, IBU", "security_type": "American Depositary Shares", "side_code": "A", "side": "Acquisition", "shares": 49558.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.689674+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "PLUMP, ANDREW STEWART", "executive_title": "Director, President, R&D", "security_type": "American Depositary Shares", "side_code": "A", "side": "Acquisition", "shares": 125390.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.722076+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "REED, KIMBERLY A.", "executive_title": "Director", "security_type": "Tax Obligation Award", "side_code": "A", "side": "Acquisition", "shares": 1319.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.665153+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "REED, KIMBERLY A.", "executive_title": "Director", "security_type": "Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 3800.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.662710+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "RICCI, GABRIELE", "executive_title": "Chief Data & Tech. Officer", "security_type": "American Depositary Shares", "side_code": "A", "side": "Acquisition", "shares": 37616.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.705301+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "SHANNON, ELAINE MARY", "executive_title": "Pres., Global Supply & Quality", "security_type": "American Depositary Shares", "side_code": "A", "side": "Acquisition", "shares": 30094.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.706888+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "SMOTER, JENNIFER MARIE", "executive_title": "Chief Comm. & Gov.  Officer", "security_type": "American Depositary Shares", "side_code": "A", "side": "Acquisition", "shares": 18808.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.691688+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "STOFFELS, PAULUS", "executive_title": "Director", "security_type": "Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 3800.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.736368+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "STOFFELS, PAULUS", "executive_title": "Director", "security_type": "Tax Obligation Award", "side_code": "A", "side": "Acquisition", "shares": 1307.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.693571+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "TSUSAKA, MIKI", "executive_title": "Director", "security_type": "Tax Obligation Award", "side_code": "A", "side": "Acquisition", "shares": 1937.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.679094+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}, {"symbol": "TAK", "name": "Takeda Pharmaceutical Co Ltd ADR", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "TSUSAKA, MIKI", "executive_title": "Director", "security_type": "Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 1800.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T21:51:45.677585+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/tak/", "research_links": {"chart": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/", "report": "/terminal/31f31298-a544-49e1-8ab7-d3caae9549ed/report/", "factor": "/factors/ticker/31f31298-a544-49e1-8ab7-d3caae9549ed/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}